Zheng Quan Ri Bao Zhi Sheng·2025-12-17 13:13Core Viewpoint - The collaboration between Shengxiang Bio and Alibaba Health represents a deep synergy of the company's "three-in-one" model and the "medical-testing-pharmacy integration" ecosystem, aiming to enhance home-based medical services and promote standardized health testing solutions [1] Group 1: Collaboration and Services - The partnership focuses on the "Respiratory Virus and Bacteria 12-in-1 Testing" project, allowing users to complete professional-level testing from home, with reports generated in an average of 3 hours, thereby alleviating the pressure on healthcare systems during flu seasons [1] - Future initiatives will include the standardization and nationwide promotion of home rapid testing services, as well as the exploration of additional home-based applications for infectious disease testing [1] Group 2: Health Ecosystem Development - The collaboration aims to drive the precision and accessibility of serious medical services, transitioning health demands towards proactive and consumer-oriented approaches [1] - The goal is to lead health consumption towards a more serious, scientific, and personalized direction, ensuring tailored health management solutions benefit every individual [1]